Corgi Insurance Launches Free Community Bus Routes Across San Francisco
SAN FRANCISCO, April 23, 2026 /PRNewswire/ — Corgi Insurance has rolled out a new initiative to better connect the city it calls home: free weekday bus routes... Read more.
HAIVISION ANNOUNCES VOTING RESULTS FROM 2026 ANNUAL MEETING OF SHAREHOLDERS
MONTRÉAL, April 23, 2026 /PRNewswire/ – Haivision Systems Inc. (“Haivision” or the “Company“) (TSX: HAI) is pleased to announce the... Read more.
Centrus to Webcast Conference Call on May 6 at 8:30 a.m. ET
BETHESDA, Md., April 23, 2026 /PRNewswire/ — Centrus Energy Corp. (NYSE: LEU) will broadcast its quarterly conference call with shareholders and the financial... Read more.
Robinson Nuclear Plant receives approval from U.S. Nuclear Regulatory Commission to continue operating until 2050
License extension supports growing energy demand, helps keep customer costs as low as possible Extended operation provides significant economic benefits for Pee... Read more.
Shopify Rebellion and Follett Higher Education Announce Collegiate Rocket League Invitational to Expand Student Engagement Through Esports
WESTCHESTER, Ill. and TORONTO, April 23, 2026 /PRNewswire/ — Follett Higher Education, North America’s leading campus retailer and education services... Read more.
Jetstream Venture Fund Establishes Interest in Shield AI, Advancing its “Future of Air and Space” Portfolio
SCOTTSDALE, Ariz., April 23, 2026 /PRNewswire/ — Jetstream Venture Fund (Jetstream), an innovative interval fund designed to expand access to venture-style... Read more.
SAP Quarterly Statement Q1 2026
WALLDORF, Germany, April 23, 2026 /PRNewswire/ — SAP SE (NYSE: SAP) announced today its financial results for the first quarter ended March 31, 2026. Current... Read more.
NHI Announces CFO Succession Plan; John Spaid to Retire, Todd Siefert Named Successor
MURFREESBORO, Tenn., April 23, 2026 /PRNewswire/ — National Health Investors, Inc. (NYSE: NHI) announced today that John Spaid, Executive Vice President and... Read more.
Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN FRANCISCO, April 23, 2026 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology... Read more.
AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.
U.S. Food and Drug Administration (FDA) issues Complete Response Letter (CRL) for trenibotulinumtoxinE (TrenibotE) related to manufacturing processes; no additional... Read more.